Andres Jerez
Overview
Explore the profile of Andres Jerez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
73
Citations
1893
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vicente A, Luna I, Ruiz J, Remigia M, Jerez A, Lluch R, et al.
Diagnostics (Basel)
. 2024 Aug;
14(15).
PMID: 39125507
The International Consensus Classification of Myeloid Neoplasms and Acute Leukemias (ICC) and the 5th edition of the WHO classification (WHO 2022) have refined the diagnosis of myelodysplastic syndromes (MDS). Both...
2.
Montoro M, Palomo L, Haferlach C, Acha P, Chan O, Navarro V, et al.
Blood
. 2024 Jul;
144(16):1722-1731.
PMID: 39074355
Mutations in the TP53 gene, particularly multihit alterations, have been associated with unfavorable clinical features and prognosis in patients diagnosed with myelodysplastic syndrome (MDS). Despite this, the role of TP53...
3.
Wang Y, Lin C, Gurashi K, Yao C, Jerez A, Hou H, et al.
Blood Cancer J
. 2024 Jul;
14(1):112.
PMID: 38997261
No abstract available.
4.
Torres-Esquius S, Beas F, Chen-Liang T, Pomares H, Santiago M, Diaz Varela N, et al.
Br J Haematol
. 2024 Apr;
205(2):503-509.
PMID: 38639421
Patients aged 50 or above diagnosed with myeloid neoplasms (MNs) are typically not candidates for germline testing. However, approximately 8% carry pathogenic germline variants. Allogeneic haematopoietic stem cell transplantation (alloHSCT)...
5.
Mosquera Orgueira A, Perez Encinas M, Diaz Varela N, Wang Y, Mora E, Diaz-Beya M, et al.
Br J Haematol
. 2024 Feb;
204(4):1529-1535.
PMID: 38411250
Chronic myelomonocytic leukaemia (CMML) is a rare haematological disorder characterized by monocytosis and dysplastic changes in myeloid cell lineages. Accurate risk stratification is essential for guiding treatment decisions and assessing...
6.
Hurtado-Navarro L, Cuenca-Zamora E, Zamora L, Bellosillo B, Such E, Soler-Espejo E, et al.
Cell Rep Med
. 2023 Dec;
4(12):101329.
PMID: 38118408
Chronic myelomonocytic leukemia (CMML) is frequently associated with mutations in the rat sarcoma gene (RAS), leading to worse prognosis. RAS mutations result in active RAS-GTP proteins, favoring myeloid cell proliferation...
7.
Mosquera Orgueira A, Perez Encinas M, Diaz Varela N, Mora E, Diaz-Beya M, Montoro M, et al.
Hemasphere
. 2023 Oct;
7(10):e961.
PMID: 37841754
Myelodysplastic neoplasms (MDS) are a heterogeneous group of hematological stem cell disorders characterized by dysplasia, cytopenias, and increased risk of acute leukemia. As prognosis differs widely between patients, and treatment...
8.
Macauda A, Briem K, Clay-Gilmour A, Cozen W, Forsti A, Giaccherini M, et al.
Leukemia
. 2023 Sep;
37(11):2326-2329.
PMID: 37723249
No abstract available.
9.
Clavero E, Sanchez-Maldonado J, Macauda A, Ter Horst R, Sampaio-Marques B, Jurczyszyn A, et al.
Int J Mol Sci
. 2023 May;
24(10).
PMID: 37239846
Multiple myeloma (MM) arises following malignant proliferation of plasma cells in the bone marrow, that secrete high amounts of specific monoclonal immunoglobulins or light chains, resulting in the massive production...
10.
Cabrera-Serrano A, Sanchez-Maldonado J, Ter Horst R, Macauda A, Garcia-Martin P, Benavente Y, et al.
Int J Mol Sci
. 2023 May;
24(9).
PMID: 37175717
Chronic lymphocytic leukemia (CLL) is the most common leukemia among adults worldwide. Although genome-wide association studies (GWAS) have uncovered the germline genetic component underlying CLL susceptibility, the potential use of...